Dissolution Profile of Tosufloxacin Tosylate in Biorelevant Bicarbonate Buffer Containing Sodium Chloride: Precipitation of Hemi-hydrochloride Salt at the Particle Surface.

IF 4.3 3区 医学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Pharmaceutical Research Pub Date : 2025-08-01 Epub Date: 2025-08-11 DOI:10.1007/s11095-025-03905-4
Nanami Okamoto, Hibiki Yamamoto, Kiyohiko Sugano
{"title":"Dissolution Profile of Tosufloxacin Tosylate in Biorelevant Bicarbonate Buffer Containing Sodium Chloride: Precipitation of Hemi-hydrochloride Salt at the Particle Surface.","authors":"Nanami Okamoto, Hibiki Yamamoto, Kiyohiko Sugano","doi":"10.1007/s11095-025-03905-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the present study was to investigate the dissolution profile of tosufloxacin tosylate monohydrate (TFLX TS) in biorelevant bicarbonate buffer (BCB). TFLX is a zwitterionic drug (pK<sub>a</sub>: 5.8 and 8.7), formulated as tosylate salt to enhance its dissolution.</p><p><strong>Methods: </strong>The dissolution profiles were measured in BCB or phosphate buffer (PPB) at pH 6.5 with buffer capacity (β) = 0.88 or 4.4 mM/pH, containing NaCl or Na<sub>2</sub>SO<sub>4</sub> (I = 0.14 M). The residual particles were analyzed by powder X-ray diffraction. In a separate study, the particle surface of TFLX TS after contact with BCB was observed by scanning electron microscopy and real-time polarized light microscopy. The pH solubility profile of TFLX was measured using HCl and TS solutions.</p><p><strong>Results: </strong>TFLX TS dissolved less in the NaCl media than in the Na<sub>2</sub>SO<sub>4</sub> media. It also dissolved less in PPB than in BCB (at β = 4.4 mM/pH), and less at β = 4.4 mM/pH than at 0.88 mM/pH. The analysis of residual particles indicated that the hemi-hydrochloride salt (TFLX 1/2HCl) precipitated on the particle surface of TFLX TS in the NaCl media. In contrast, the free form of TFLX precipitated in the Na<sub>2</sub>SO<sub>4</sub> media. The pH solubility profile matched the hemi-hydrochloride stoichiometry (K<sub>sp</sub> = [TFLX∙H<sup>+</sup>][TFLX][Cl<sup>-</sup>]).</p><p><strong>Conclusion: </strong>The dissolution of TFLX TS in the NaCl media was suppressed by the precipitation of TFLX 1/2HCl on the particle surface. This is an important case showing that NaCl can suppress the dissolution profile of a non-HCl drug salt at a neutral pH.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":"1363-1372"},"PeriodicalIF":4.3000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405044/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-025-03905-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The purpose of the present study was to investigate the dissolution profile of tosufloxacin tosylate monohydrate (TFLX TS) in biorelevant bicarbonate buffer (BCB). TFLX is a zwitterionic drug (pKa: 5.8 and 8.7), formulated as tosylate salt to enhance its dissolution.

Methods: The dissolution profiles were measured in BCB or phosphate buffer (PPB) at pH 6.5 with buffer capacity (β) = 0.88 or 4.4 mM/pH, containing NaCl or Na2SO4 (I = 0.14 M). The residual particles were analyzed by powder X-ray diffraction. In a separate study, the particle surface of TFLX TS after contact with BCB was observed by scanning electron microscopy and real-time polarized light microscopy. The pH solubility profile of TFLX was measured using HCl and TS solutions.

Results: TFLX TS dissolved less in the NaCl media than in the Na2SO4 media. It also dissolved less in PPB than in BCB (at β = 4.4 mM/pH), and less at β = 4.4 mM/pH than at 0.88 mM/pH. The analysis of residual particles indicated that the hemi-hydrochloride salt (TFLX 1/2HCl) precipitated on the particle surface of TFLX TS in the NaCl media. In contrast, the free form of TFLX precipitated in the Na2SO4 media. The pH solubility profile matched the hemi-hydrochloride stoichiometry (Ksp = [TFLX∙H+][TFLX][Cl-]).

Conclusion: The dissolution of TFLX TS in the NaCl media was suppressed by the precipitation of TFLX 1/2HCl on the particle surface. This is an important case showing that NaCl can suppress the dissolution profile of a non-HCl drug salt at a neutral pH.

Abstract Image

Abstract Image

Abstract Image

tosuflo沙星tosy酸酯在含氯化钠的生物相关碳酸氢盐缓冲液中的溶解谱:半盐酸盐在颗粒表面的沉淀。
目的:研究tosuflo沙星tosuflo沙星一水酯(TFLX TS)在生物相关碳酸氢盐缓冲液(BCB)中的溶出度。TFLX是一种两性离子药物(pKa: 5.8和8.7),配制成tosylate盐以增强其溶解性。方法:在pH为6.5,缓冲容量(β) = 0.88或4.4 mM/pH,含NaCl或Na2SO4 (I = 0.14 M)的BCB或磷酸盐缓冲液(PPB)中测定溶出曲线。用粉末x射线衍射对残余颗粒进行了分析。在另一项研究中,通过扫描电镜和实时偏振光显微镜观察了TFLX TS与BCB接触后的颗粒表面。用HCl和TS溶液测定了TFLX的pH溶解度。结果:TFLX TS在NaCl介质中的溶解量小于在Na2SO4介质中的溶解量。当β = 4.4 mM/pH时,其在PPB中的溶解量小于在BCB中的溶解量,当β = 4.4 mM/pH时,其溶解量小于0.88 mM/pH。残留颗粒分析表明,在NaCl介质中,半盐酸盐(TFLX 1/2HCl)沉淀在TFLX TS颗粒表面。而自由形态的TFLX则在Na2SO4介质中析出。pH溶解度分布符合半盐酸盐化学计量(Ksp = [TFLX∙H+][TFLX][Cl-])。结论:TFLX 1/2HCl在颗粒表面的沉淀抑制了TFLX TS在NaCl介质中的溶解。这是一个重要的例子,表明NaCl可以抑制非hcl药物盐在中性pH下的溶解谱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceutical Research
Pharmaceutical Research 医学-化学综合
CiteScore
6.60
自引率
5.40%
发文量
276
审稿时长
3.4 months
期刊介绍: Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to: -(pre)formulation engineering and processing- computational biopharmaceutics- drug delivery and targeting- molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)- pharmacokinetics, pharmacodynamics and pharmacogenetics. Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信